Skip to content
ClinicalEvidence

Clinical trial intelligence for pharma clinical development and strategy

Know which competitor trials are running, what they measure and when they report, with every statement cited to the registry record or publication it comes from.

Clinician reading a printed trial protocol

Competitive trial landscape work in pharma

Clinical development, competitive intelligence and portfolio strategy teams answer the same kind of question every week. Which sponsors have a phase 3 trial in our indication, what primary endpoint did they choose, how many patients are they enrolling, and has anyone posted results. The answers live in several places at once: ClinicalTrials.gov, the EU Clinical Trials Register and CTIS, the WHO ICTRP portal and PubMed.

Pulling them together by hand means exporting registry records, cleaning columns, reconciling the same study registered under different identifiers and reading abstracts to see whether a readout has been published. The work repeats every time a protocol is amended or a new trial appears, and a slide built on last quarter's export quietly goes out of date.

  • Registry records list studies, they do not answer the strategic question
  • The same trial can appear in several registries with different identifiers
  • Endpoint and enrolment changes are easy to miss between reviews
  • A claim without a source does not survive a governance meeting

A typical competitor trial review in ClinicalEvidence

  1. 1. Ask the question in plain English, for example which phase 2 and phase 3 trials test oral GLP-1 receptor agonists in obesity and who sponsors them.

  2. 2. Read the cited answer. Every sentence carries the NCT numbers or PMIDs it rests on, and each citation is checked against the index before the answer is shown.

  3. 3. Open the trial table and filter by phase, status, sponsor type, country and results available. Sort by primary completion date to see which readouts come next.

  4. 4. Run a comparison of two to four interventions to see endpoints, populations and posted outcomes side by side.

  5. 5. Save the question and turn on an alert, so the team gets an email when a new trial or publication matches.

  6. 6. Export the table to XLSX for the portfolio deck, or to DOCX with a reference list for the internal memo.

Features that matter for pipeline monitoring

  • Cited answers with sentence level NCT and PMID links, verified before display
  • A clinical trial table with phase, population, interventions, primary and secondary endpoints, sponsor, status, enrolment, dates and locations
  • Intervention comparisons for two to four competing assets
  • Alerts on competitor trials delivered by email on saved questions
  • Shared workspaces, saved threads, comments and roles for the whole team
  • An audit log of who asked what and which sources were used

When the index holds no evidence for a question, ClinicalEvidence says so plainly. It never fills the gap from model memory, which matters when a slide will be read by people who make investment decisions.

Recommended plan for pharma teams

Organization costs 499 USD per month, or 249 USD per month billed yearly (2 988 USD). It includes 2 000 cited answers per month pooled across 10 seats, up to 250 per day, trial tables of up to 500 studies per answer, 100 alerts, bulk CSV export, an audit log and invoicing.

Larger groups that need single sign-on choose Enterprise at 1 490 USD per month, or 745 USD per month billed yearly (8 940 USD), with 6 000 cited answers pooled, up to 50 seats, trial tables of up to 1 000 studies, 500 alerts, every export format, SAML single sign-on and priority support with a named contact. All plans and limits are on the pricing page.

Questions from pharma teams

Which sources does ClinicalEvidence search for competitor trials?

It searches its own index of ClinicalTrials.gov, the EU Clinical Trials Register, WHO ICTRP, PubMed and the PubMed Central open access subset, refreshed daily. The Sources searched panel lists only the sources used for each answer.

Does ClinicalEvidence use our confidential pipeline data?

No. ClinicalEvidence works on public registries and published literature. You do not need to upload internal documents or patient data to use it.

How do alerts on competitor trials work?

You save a question or a filtered search and turn on an alert. When a new trial or publication in the index matches it, the team receives an email with the matching records.

Start monitoring the trial landscape with sources attached

Create your account, pick a team plan and ask your first competitive question in minutes.